莱茵生物跌2.06%，成交额1.65亿元，主力资金净流出2021.25万元

Group 1 - The core viewpoint of the news is that 莱茵生物 (Laiyin Bio) has experienced a decline in stock price and significant net outflow of funds, despite a year-to-date increase in stock price [1] - As of January 14, 莱茵生物's stock price was 9.03 yuan per share, with a total market capitalization of 6.697 billion yuan [1] - The company has seen a year-to-date stock price increase of 6.86%, with a 7.12% increase over the last five trading days [1] Group 2 - For the period from January to September 2025, 莱茵生物 reported revenue of 1.272 billion yuan, representing a year-on-year growth of 8.73% [2] - The net profit attributable to shareholders for the same period was 70.3953 million yuan, which is a decrease of 30.73% year-on-year [2] - The number of shareholders as of September 30 was 46,000, a decrease of 1.66% from the previous period [2] Group 3 - Since its A-share listing, 莱茵生物 has distributed a total of 431 million yuan in dividends, with 294 million yuan distributed over the last three years [3]